419 results on '"Mezlini, Amel"'
Search Results
2. Predictors of pathological complete response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
3. Decreased risk of ovarian cancer associated with rs9898876 sex hormone-binding globulin gene variant
4. Clinico-Epidemiological Profile, Prognostic Factors and Treatment Outcome of Refractory Hodgkin Lymphoma
5. Evaluation of cfDNA as an early detection assay for dense tissue breast cancer
6. sHLA-G as a biomarker for colorectal cancer pathogenesis
7. Association of HLA-G 3′UTR polymorphisms and haplotypes with colorectal cancer susceptibility and prognosis
8. VISTA/CTLA4/PD1 coexpression on tumor cells confers a favorable immune microenvironment and better prognosis in high-grade serous ovarian carcinoma
9. HLA class II polymorphisms as prognostic biomarkers for right and left-sided colon cancer
10. Study on Metastatic Clear Cell Hidradenocarcinoma: An Approach towards Response to Chemotherapy and Long Disease Control
11. Risk factors for inflammatory and non-inflammatory breast cancer in North Africa
12. Interleukin-17A polymorphisms predict the response and development of tolerance to FOLFOX chemotherapy in colorectal cancer treatment
13. Association of Combined Tobacco Smoking, Hormonal Contraceptive use and Status Matrimonial with Cervical Cancer Evolution in Tunisian Women
14. Effects of combined supervised intermittent aerobic, muscle strength and home-based walking training programs on cardiorespiratory responses in women with breast cancer
15. Primary adenocarcinoma of the upper esophagus: A rare presentation
16. #209 Uncommon tumor in an adult woman: rhabdomyosarcoma of the uterine cervix
17. #211 A rare case of persistent mullerian duct syndrome with testicular seminoma
18. Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa
19. Variant Characterization of a Representative Large Pedigree Suggests “Variant Risk Clusters” Convey Varying Predisposition of Risk to Lynch Syndrome
20. PB2340: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONGPATIENTS AGED LESS THAN 60 YEARS: A TUNISIAN MULTICENTER EXPERIENCE.
21. PB2320: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONG THE ELDERLY: A TUNISIAN MULTICENTER EXPERIENCE.
22. Immune checkpoints as potential theragnostic biomarkers for epithelial ovarian cancer
23. Rhabdomyosarcoma in Uterine Cervix: A 30-Year-Old Tunisian Woman Case Report
24. Western influenced lifestyle and Kv2.1 association as predicted biomarkers for Tunisian colorectal cancer
25. VISTA+/CD8+ status correlates with favorable prognosis in Epithelial ovarian cancer
26. Variant Characterization of a Representative Large Pedigree Suggests “Variant Risk Clusters” Convey Varying Predisposition of Risk to Lynch Syndrome
27. Identification of two theranostic biomarker panels for epithelial ovarian cancer
28. An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction
29. Effect of Follicle Stimulating Hormone Receptor Gene Polymorphisms in Cervical Cancer Risk
30. Relationships between Common and Novel Interleukin-6 Gene Polymorphisms and Risk of Cervical Cancer: a Case-Control Study
31. Association of HLA-G +3142 C>G polymorphism and breast cancer in Tunisian population
32. Pregnancy and breastfeeding: a new theory for sHLA-G in breast cancer patients?
33. Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution
34. Effects of multimodal training program on muscle deoxygenation in women with breast cancer: A randomized controlled trial
35. Larynx preservation: What is the best non-surgical strategy?
36. Interleukin-1 Gene Cluster Polymorphisms and its Haplotypes may Predict the Risk to Develop Cervical Cancer in Tunisia
37. Tumor Necrosis Factor Alpha (−238 / −308) and TNFRII-VNTR (−322) Polymorphisms as Genetic Biomarkers of Susceptibility to Develop Cervical Cancer Among Tunisians
38. MP40-09 THE SYSTEMIC IMMUNE–INFLAMMATION INDEX (SII) AS PREDICTOR FACTOR OF SURVIVAL IN PATIENTS UNDERGOING RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA
39. Descriptive Epidemiology of Malignant primary osteosarcoma in Tunisia 1980-2016
40. Skin toxicity after Filgrastim treatment for an Ewing's sarcoma patient
41. Clinical and pathological characteristics, treatment outcome and prognostic factors in adult rhabdomyosarcoma: a monocentric retrospective study
42. Wild-type genotypes of BRCA1 gene SNPs combined with micro-RNA over-expression in mammary tissue leading to familial breast cancer with an increased risk of distant metastases’ occurrence
43. Significant association between interleukin-17A polymorphism and colorectal cancer
44. Impact of lifestyle factors and nutrients intake on occurrence of gastrointestinal cancer in Tunisian population
45. 3020insC NOD2/CARD15 polymorphism associated with treatment of colorectal cancer
46. Thymidylate synthase polymorphism in sporadic colorectal and gastric cancer in Tunisian population: a predictive role in 5-fluorouracil based chemotherapy treatment
47. Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis
48. Rhabdomyosarcoma in Uterine Cervix: A 30-Year-Old Tunisian Woman Case Report.
49. IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians
50. Decreased Risk of Ovarian Cancer Associated With rs9898876 Sex Hormone-binding Globulin Gene Variant
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.